COVID-19 and myasthenia gravis: A review of neurological implications of the SARS-COV-2.
Syed Muhammad Ismail ShahFarah YasminRoha Saeed MemonNadia Nazir JatoiIlma Saleh SavulSana KazmiSyed Abdullah MonawwerMuhammad Daim Bin ZafarMuhammad Sohaib AsgharMuhammad Junaid TahirKa Yiu LeePublished in: Brain and behavior (2022)
Further clinical studies are warranted to indicate and rather confirm if MG in the setting of COVID-19 can pre-existent subclinically or develop as a new-onset disease.